Please Wait

Applying Filters...

Drug Product Composition: 01885_FLUKA

01885_FLUKA

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

90 API Suppliers, 40 USDMF, 28 CEP/COS, 10 JDMF, 13 EU WC, 13 KDMF, 14 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

91 Drugs in Development

91 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

297 FDF Dossiers, 87 FDA Orange Book, 99 Europe, 4 Canada, 8 Australia, 30 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 2 Actylis, 2 BASF, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 7 Parenteral, 7 Topical, 4 Emulsifying Agents, 4 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 3 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 Coating Systems & Additives, 1 API Stability Enhancers, 1 Co-Processed Excipients, 1 Direct Compression

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 135 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 55 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

13 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

44 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 4 JP, 16 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22534 / DOSAGE - INJECTABLE;INJECTION - 80MG/VIAL

Drug Product Composition: 01885_FLUKA

01885_FLUKA

01885_FLUKA

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

90 API Suppliers

40 USDMF

28 CEP/COS

10 JDMF

13 EU WC

13 KDMF

14 NDC API

41 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

91 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

297 FDF Dossiers

87 FDA Orange Book

99 Europe

4 Canada

8 Australia

30 South Africa

69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/2ML (40MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/VIAL

INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd

3 Nanjing Well Pharmaceutical

2 Actylis

2 BASF

1 Clariant

1 Finar

3 Gangwal Chemicals

1 Nanjing Bold Chemical

6 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers

7 Parenteral

7 Topical

4 Emulsifying Agents

4 Thickeners and Stabilizers

4 Film Formers & Plasticizers

3 Surfactant & Foaming Agents

2 Rheology Modifiers

1 Coating Systems & Additives

1 API Stability Enhancers

1 Co-Processed Excipients

1 Direct Compression

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Stock Recap #PipelineProspector

135 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions

55 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

13 APIs

14 FDF Dossiers

PATENTS & EXCLUSIVITIES

INJECTABLE;INJECTION - 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons